Other news to note
Bind Therapeutics Inc., of Cambridge, Mass., and Amgen Inc., of Thousand Oaks, Calif., amended their development and commercialization collaboration agreement to extend the period during which Amgen may exercise its option by six months.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter